Current Opinion in Oncology, ISSN 1040-8746, 09/2015, Volume 27, Issue 5, pp. 392 - 398
PURPOSE OF REVIEWEpstein–Barr virus (EBV)-positive diffuse large B-cell lymphoma (DLBCL) of the elderly is an EBV-positive monoclonal large B-cell...
SURVIVAL | CD30 | POPULATION | ACTIVATION | EBV-positive DLBCL of the elderly | WESTERN COUNTRIES | PREVALENCE | prognosis | IMMUNOSENESCENCE | ONCOLOGY | PATHWAY | young adults | gene expression profiles | EBV | LYMPHOPROLIFERATIVE DISORDERS | AGE | Prevalence | Prognosis | Lymphoma, Large B-Cell, Diffuse - pathology | Oligonucleotide Array Sequence Analysis | Humans | Gene Expression Regulation, Neoplastic | European Continental Ancestry Group | NF-kappa B - metabolism | Gene Expression Profiling | Lymphoma, Large B-Cell, Diffuse - etiology | Epstein-Barr Virus Infections - pathology | Asian Continental Ancestry Group | Lymphoma, Large B-Cell, Diffuse - epidemiology | Aged, 80 and over | B-Lymphocytes - virology | Epstein-Barr Virus Infections - genetics | Epstein-Barr Virus Infections - complications | Aged | Herpesvirus 4, Human - pathogenicity | American Native Continental Ancestry Group | Lymphoma, Large B-Cell, Diffuse - genetics | B-Lymphocytes - metabolism | Cluster Analysis | Epstein-Barr Virus Infections - epidemiology
SURVIVAL | CD30 | POPULATION | ACTIVATION | EBV-positive DLBCL of the elderly | WESTERN COUNTRIES | PREVALENCE | prognosis | IMMUNOSENESCENCE | ONCOLOGY | PATHWAY | young adults | gene expression profiles | EBV | LYMPHOPROLIFERATIVE DISORDERS | AGE | Prevalence | Prognosis | Lymphoma, Large B-Cell, Diffuse - pathology | Oligonucleotide Array Sequence Analysis | Humans | Gene Expression Regulation, Neoplastic | European Continental Ancestry Group | NF-kappa B - metabolism | Gene Expression Profiling | Lymphoma, Large B-Cell, Diffuse - etiology | Epstein-Barr Virus Infections - pathology | Asian Continental Ancestry Group | Lymphoma, Large B-Cell, Diffuse - epidemiology | Aged, 80 and over | B-Lymphocytes - virology | Epstein-Barr Virus Infections - genetics | Epstein-Barr Virus Infections - complications | Aged | Herpesvirus 4, Human - pathogenicity | American Native Continental Ancestry Group | Lymphoma, Large B-Cell, Diffuse - genetics | B-Lymphocytes - metabolism | Cluster Analysis | Epstein-Barr Virus Infections - epidemiology
Journal Article
JOURNAL OF CRANIOFACIAL SURGERY, ISSN 1049-2275, 05/2019, Volume 30, Issue 3, pp. E259 - E262
Lymphomas of the oral cavity are rare and the most frequent type is diffuse large B-cell lymphoma (DLBCL). EpsteinBarr virus (EBV) is known to be associated...
SURVIVAL | SURGERY | NON-HODGKIN LYMPHOMAS | MAXILLOFACIAL REGION | elderly | CLASSIFICATION | diffuse large B-cell lymphoma | non-hodgkin lymphoma | EBV | Epstein-Barr virus | UPDATE | LYMPHOPROLIFERATIVE DISORDERS | B-cell lymphoma
SURVIVAL | SURGERY | NON-HODGKIN LYMPHOMAS | MAXILLOFACIAL REGION | elderly | CLASSIFICATION | diffuse large B-cell lymphoma | non-hodgkin lymphoma | EBV | Epstein-Barr virus | UPDATE | LYMPHOPROLIFERATIVE DISORDERS | B-cell lymphoma
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2015, Volume 10, Issue 7, p. e0133973
Background Epstein-Barr virus (EBV)-positive diffuse large B-cell lymphoma (DLBCL) in the elderly has rarely been reported. This study aimed to explore the...
RITUXIMAB-CHOP | DLBCL | THERAPY | MULTIDISCIPLINARY SCIENCES | LENALIDOMIDE | IBRUTINIB | OPEN-LABEL | LYMPHOPROLIFERATIVE DISORDERS | COMBINATION | INHIBITOR | CHEMOTHERAPY | Doxorubicin - therapeutic use | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - pathology | Herpesvirus 4, Human - physiology | Humans | Middle Aged | Etoposide - therapeutic use | Male | Treatment Outcome | Lymphoma, Large B-Cell, Diffuse - metabolism | Case-Control Studies | Cyclophosphamide - therapeutic use | Lymphoma, Large B-Cell, Diffuse - virology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Survival Analysis | Vincristine - therapeutic use | Female | Aged | Retrospective Studies | Prednisone - therapeutic use | Physiological aspects | Aged patients | Care and treatment | Lymphomas | Diagnosis | Epstein-Barr virus diseases | Elderly people | Immunohistochemistry | Laboratories | Viruses | Oncology | Infections | Hybridization | Kinases | Cancer therapies | CD30 antigen | Remission | Age | Gene expression | Disease control | Patients | Survival | Lymphoma | Medicine | Chemotherapy | Lymphocytes B | Collaboration | Medical prognosis | Elderly | Geriatrics | Tumors | B-cell lymphoma
RITUXIMAB-CHOP | DLBCL | THERAPY | MULTIDISCIPLINARY SCIENCES | LENALIDOMIDE | IBRUTINIB | OPEN-LABEL | LYMPHOPROLIFERATIVE DISORDERS | COMBINATION | INHIBITOR | CHEMOTHERAPY | Doxorubicin - therapeutic use | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - pathology | Herpesvirus 4, Human - physiology | Humans | Middle Aged | Etoposide - therapeutic use | Male | Treatment Outcome | Lymphoma, Large B-Cell, Diffuse - metabolism | Case-Control Studies | Cyclophosphamide - therapeutic use | Lymphoma, Large B-Cell, Diffuse - virology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Survival Analysis | Vincristine - therapeutic use | Female | Aged | Retrospective Studies | Prednisone - therapeutic use | Physiological aspects | Aged patients | Care and treatment | Lymphomas | Diagnosis | Epstein-Barr virus diseases | Elderly people | Immunohistochemistry | Laboratories | Viruses | Oncology | Infections | Hybridization | Kinases | Cancer therapies | CD30 antigen | Remission | Age | Gene expression | Disease control | Patients | Survival | Lymphoma | Medicine | Chemotherapy | Lymphocytes B | Collaboration | Medical prognosis | Elderly | Geriatrics | Tumors | B-cell lymphoma
Journal Article
International Journal of Cancer, ISSN 0020-7136, 12/2014, Volume 135, Issue 12, pp. 2816 - 2824
Diffuse large B‐cell lymphoma (DLBCL), the most common group of malignant lymphomas, account for 30% of adult non‐Hodgkin lymphomas. The 2008 World Health...
Epstein‐Barr virus latency pattern | diffuse large B‐cell lymphoma | T‐cell markers | young adults | elderly | Epstein‐Barr virus | Diffuse large b-cell lymphoma | Epstein-Barr virus | Young adults | Epstein-Barr virus latency pattern | T-cell markers | Elderly | CLASSIFICATION | PATTERNS | diffuse large B-cell lymphoma | PREVALENCE | MOLECULES | MICROENVIRONMENT | ONCOLOGY | DISEASE | LYMPHOPROLIFERATIVE DISORDERS | T-CELLS | REVEALS | MEXICAN | Argentina | Prevalence | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Male | Lymphoma, Large B-Cell, Diffuse - metabolism | Herpesvirus 4, Human | Lymphoma, Large B-Cell, Diffuse - virology | Young Adult | In Situ Hybridization | T-Lymphocytes - cytology | Biopsy | Lymphoma, Large B-Cell, Diffuse - epidemiology | Adolescent | Aged, 80 and over | Adult | Female | Aged | Immunosuppressive Agents - pharmacology | Cohort Studies | Immunohistochemistry | Analysis | Immunotherapy | Aged patients | Lymphomas | T cells | Gene expression | Medical research | Pathogenesis | Age
Epstein‐Barr virus latency pattern | diffuse large B‐cell lymphoma | T‐cell markers | young adults | elderly | Epstein‐Barr virus | Diffuse large b-cell lymphoma | Epstein-Barr virus | Young adults | Epstein-Barr virus latency pattern | T-cell markers | Elderly | CLASSIFICATION | PATTERNS | diffuse large B-cell lymphoma | PREVALENCE | MOLECULES | MICROENVIRONMENT | ONCOLOGY | DISEASE | LYMPHOPROLIFERATIVE DISORDERS | T-CELLS | REVEALS | MEXICAN | Argentina | Prevalence | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Male | Lymphoma, Large B-Cell, Diffuse - metabolism | Herpesvirus 4, Human | Lymphoma, Large B-Cell, Diffuse - virology | Young Adult | In Situ Hybridization | T-Lymphocytes - cytology | Biopsy | Lymphoma, Large B-Cell, Diffuse - epidemiology | Adolescent | Aged, 80 and over | Adult | Female | Aged | Immunosuppressive Agents - pharmacology | Cohort Studies | Immunohistochemistry | Analysis | Immunotherapy | Aged patients | Lymphomas | T cells | Gene expression | Medical research | Pathogenesis | Age
Journal Article
Cancer Science, ISSN 1347-9032, 09/2014, Volume 105, Issue 9, pp. 1170 - 1175
Diffuse large B‐cell lymphoma (DLBCL) is the most common subtype of malignant lymphoma. The incidence of Epstein–Barr virus (EBV)‐positive DLBCL in Asian and...
Diffuse large B‐cell lymphoma | prognosis | Epstein–Barr virus (EBV) | Epstein-Barr virus (EBV) | Prognosis | Diffuse large B-cell lymphoma | DLBCL | ONCOLOGY | EBV | CHOP | CLASSIFICATION | GERMINAL CENTER | LYMPHOPROLIFERATIVE DISORDERS | DES-LYMPHOMES | Doxorubicin - therapeutic use | Lymphoma, Large B-Cell, Diffuse - drug therapy | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Kaplan-Meier Estimate | Proportional Hazards Models | Rituximab | Male | Treatment Outcome | Cyclophosphamide - therapeutic use | Lymphoma, Large B-Cell, Diffuse - virology | Lymphoma, Large B-Cell, Diffuse - mortality | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Vincristine - therapeutic use | Epstein-Barr Virus Infections - mortality | Epstein-Barr Virus Infections - complications | Female | Aged | Prednisone - therapeutic use | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Antimitotic agents | Chemotherapy | Patient outcomes | Lymphomas | Epstein-Barr virus | Antineoplastic agents | Cancer | Medical research | Antigens | Leukemia | Nervous system | Infections | Hybridization | Ribonucleic acid--RNA | Lymphoma | Lymphocytes B | Human immunodeficiency virus--HIV | Medical prognosis | Geriatrics | Original
Diffuse large B‐cell lymphoma | prognosis | Epstein–Barr virus (EBV) | Epstein-Barr virus (EBV) | Prognosis | Diffuse large B-cell lymphoma | DLBCL | ONCOLOGY | EBV | CHOP | CLASSIFICATION | GERMINAL CENTER | LYMPHOPROLIFERATIVE DISORDERS | DES-LYMPHOMES | Doxorubicin - therapeutic use | Lymphoma, Large B-Cell, Diffuse - drug therapy | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Kaplan-Meier Estimate | Proportional Hazards Models | Rituximab | Male | Treatment Outcome | Cyclophosphamide - therapeutic use | Lymphoma, Large B-Cell, Diffuse - virology | Lymphoma, Large B-Cell, Diffuse - mortality | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Vincristine - therapeutic use | Epstein-Barr Virus Infections - mortality | Epstein-Barr Virus Infections - complications | Female | Aged | Prednisone - therapeutic use | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Antimitotic agents | Chemotherapy | Patient outcomes | Lymphomas | Epstein-Barr virus | Antineoplastic agents | Cancer | Medical research | Antigens | Leukemia | Nervous system | Infections | Hybridization | Ribonucleic acid--RNA | Lymphoma | Lymphocytes B | Human immunodeficiency virus--HIV | Medical prognosis | Geriatrics | Original
Journal Article
World Neurosurgery, ISSN 1878-8750, 01/2020, Volume 133, pp. 10 - 13
Epstein-Barr virus (EBV)–positive diffuse large B-cell lymphoma (DLBCL) in an immunocompromised patient with organ transplantation demonstrated unusual brain...
Radiology | Epstein-Barr virus | Multiple biopsy | Immunocompromised host | Lymphoma | Central nervous system
Radiology | Epstein-Barr virus | Multiple biopsy | Immunocompromised host | Lymphoma | Central nervous system
Journal Article
Human Pathology, ISSN 0046-8177, 2010, Volume 41, Issue 3, pp. 352 - 357
Summary In the currently published World Health Organization-Classification, the new entity of Epstein-Barr virus–positive diffuse large B-cell lymphoma of the...
Pathology | EBV | Diffuse large b-cell lymphoma | Epstein barr virus | EBV-positive diffuse large b-cell lymphoma of the elderly | DISEASE | MALIGNANCIES | TISSUE MICROARRAY | PATHOLOGY | LYMPHOPROLIFERATIVE DISORDERS | LYMPHOCYTES | Immunohistochemistry | Prognosis | Tissue Array Analysis | Humans | Middle Aged | Male | Necrosis - pathology | Necrosis - virology | Incidence | Patient Selection | In Situ Hybridization | Aged, 80 and over | Adult | Female | Child | Epstein-Barr Virus Infections - epidemiology | Epstein-Barr Virus Infections - virology | Lymphoma, Large B-Cell, Diffuse - pathology | Kaplan-Meier Estimate | European Continental Ancestry Group | Herpesvirus 4, Human | Ki-1 Antigen | Lymphoma, Large B-Cell, Diffuse - virology | Epstein-Barr Virus Infections - pathology | Lymphoma, Large B-Cell, Diffuse - epidemiology | RNA, Viral | Adolescent | Aged | Medical colleges | Aged patients | Lymphomas | Public health
Pathology | EBV | Diffuse large b-cell lymphoma | Epstein barr virus | EBV-positive diffuse large b-cell lymphoma of the elderly | DISEASE | MALIGNANCIES | TISSUE MICROARRAY | PATHOLOGY | LYMPHOPROLIFERATIVE DISORDERS | LYMPHOCYTES | Immunohistochemistry | Prognosis | Tissue Array Analysis | Humans | Middle Aged | Male | Necrosis - pathology | Necrosis - virology | Incidence | Patient Selection | In Situ Hybridization | Aged, 80 and over | Adult | Female | Child | Epstein-Barr Virus Infections - epidemiology | Epstein-Barr Virus Infections - virology | Lymphoma, Large B-Cell, Diffuse - pathology | Kaplan-Meier Estimate | European Continental Ancestry Group | Herpesvirus 4, Human | Ki-1 Antigen | Lymphoma, Large B-Cell, Diffuse - virology | Epstein-Barr Virus Infections - pathology | Lymphoma, Large B-Cell, Diffuse - epidemiology | RNA, Viral | Adolescent | Aged | Medical colleges | Aged patients | Lymphomas | Public health
Journal Article
Human Pathology, ISSN 0046-8177, 2015, Volume 46, Issue 5, pp. 716 - 724
Summary Pediatric Epstein-Barr virus (EBV)–positive diffuse large B-cell lymphoma (EBV+ DLBCL) is a rare disease in nonimmunocompromised hosts. In a review of...
Pathology | Children | Epstein-Barr virus (EBV) | Asia | Diffuse large B-cell lymphoma (DLBCL) | PATTERNS | HODGKIN-LYMPHOMA | CHILDHOOD | FEATURES | ADOLESCENTS | EBV | LYMPHOPROLIFERATIVE DISORDERS | ASSOCIATION | EXPRESSION | AGE | Lymphoma, Large B-Cell, Diffuse - pathology | Humans | Child, Preschool | Male | Lymphoma, Large B-Cell, Diffuse - virology | Epstein-Barr Virus Infections - pathology | Herpesvirus 4, Human - isolation & purification | Lymphoma, Large B-Cell, Diffuse - diagnosis | Adolescent | Aging | Genes, Immunoglobulin Heavy Chain - genetics | Epstein-Barr Virus Infections - diagnosis | Female | Immunophenotyping - methods | Child | In Situ Hybridization - methods | Lymphomas | Aged | Epstein-Barr virus | Immunoglobulin A | Pediatrics | Lymphatic system | Disease | Infections | Histology | Hybridization | Polymerase chain reaction | Hospitals | Lymphocytes | Classification | Gangrene | Age | Viral infections | Immune system
Pathology | Children | Epstein-Barr virus (EBV) | Asia | Diffuse large B-cell lymphoma (DLBCL) | PATTERNS | HODGKIN-LYMPHOMA | CHILDHOOD | FEATURES | ADOLESCENTS | EBV | LYMPHOPROLIFERATIVE DISORDERS | ASSOCIATION | EXPRESSION | AGE | Lymphoma, Large B-Cell, Diffuse - pathology | Humans | Child, Preschool | Male | Lymphoma, Large B-Cell, Diffuse - virology | Epstein-Barr Virus Infections - pathology | Herpesvirus 4, Human - isolation & purification | Lymphoma, Large B-Cell, Diffuse - diagnosis | Adolescent | Aging | Genes, Immunoglobulin Heavy Chain - genetics | Epstein-Barr Virus Infections - diagnosis | Female | Immunophenotyping - methods | Child | In Situ Hybridization - methods | Lymphomas | Aged | Epstein-Barr virus | Immunoglobulin A | Pediatrics | Lymphatic system | Disease | Infections | Histology | Hybridization | Polymerase chain reaction | Hospitals | Lymphocytes | Classification | Gangrene | Age | Viral infections | Immune system
Journal Article
The Oncologist, ISSN 1083-7159, 01/2011, Volume 16, Issue 1, pp. 87 - 96
Epstein‐Barr virus–positive (EBV‐positive) diffuse large B‐cell lymphoma (DLBCL) of the elderly is a newly described lymphoproliferative disorder recently...
Diffuse large B‐cell lymphoma | EBV | DLBCL | Review | Elderly | Epstein‐Barr virus | Diffuse large b-cell lymphoma | Epstein-barr virus | TRANSFORMATION | LMP1 | Diffuse large B-cell lymphoma | ONCOLOGY | JAPANESE POPULATION | DISEASE | CHOP | Epstein-Barr virus | HODGKIN LYMPHOMA | LYMPHOPROLIFERATIVE DISORDERS | EXPRESSION | ASSOCIATION | NERVOUS-SYSTEM LYMPHOMA | Herpesvirus 4, Human - isolation & purification | Prognosis | Epstein-Barr Virus Infections - virology | Lymphoma, Large B-Cell, Diffuse - pathology | Herpesvirus 4, Human - physiology | Humans | Aged | Cell Transformation, Viral | Lymphoma, Large B-Cell, Diffuse - virology | Epstein-Barr Virus Infections - pathology | Lymphoma
Diffuse large B‐cell lymphoma | EBV | DLBCL | Review | Elderly | Epstein‐Barr virus | Diffuse large b-cell lymphoma | Epstein-barr virus | TRANSFORMATION | LMP1 | Diffuse large B-cell lymphoma | ONCOLOGY | JAPANESE POPULATION | DISEASE | CHOP | Epstein-Barr virus | HODGKIN LYMPHOMA | LYMPHOPROLIFERATIVE DISORDERS | EXPRESSION | ASSOCIATION | NERVOUS-SYSTEM LYMPHOMA | Herpesvirus 4, Human - isolation & purification | Prognosis | Epstein-Barr Virus Infections - virology | Lymphoma, Large B-Cell, Diffuse - pathology | Herpesvirus 4, Human - physiology | Humans | Aged | Cell Transformation, Viral | Lymphoma, Large B-Cell, Diffuse - virology | Epstein-Barr Virus Infections - pathology | Lymphoma
Journal Article
10.
Full Text
Age cutoff for Epstein-Barr virus-positive diffuse large B-cell lymphoma--is it necessary?
Oncotarget, ISSN 1949-2553, 2015, Volume 6, Issue 16, pp. 13933 - 13945
Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly (EBV+ DLBCL-e) is a molecularly distinct variant of DLBCL, characterized by a...
EBV | DLBCL | Gene expression profiling | Elderly | Immunohistochemistry | Age Factors | Lymphoma, Large B-Cell, Diffuse - pathology | Humans | Middle Aged | Immunophenotyping | Male | Treatment Outcome | Gene Expression Profiling | Lymphoma, Large B-Cell, Diffuse - metabolism | Lymphoma, Large B-Cell, Diffuse - virology | Epstein-Barr Virus Infections - pathology | Young Adult | Animals | In Situ Hybridization | Adolescent | Aged, 80 and over | Biomarkers, Tumor - metabolism | Epstein-Barr Virus Infections - genetics | Adult | Female | Aged | Epstein-Barr Virus Infections - metabolism | Lymphoma, Large B-Cell, Diffuse - genetics
EBV | DLBCL | Gene expression profiling | Elderly | Immunohistochemistry | Age Factors | Lymphoma, Large B-Cell, Diffuse - pathology | Humans | Middle Aged | Immunophenotyping | Male | Treatment Outcome | Gene Expression Profiling | Lymphoma, Large B-Cell, Diffuse - metabolism | Lymphoma, Large B-Cell, Diffuse - virology | Epstein-Barr Virus Infections - pathology | Young Adult | Animals | In Situ Hybridization | Adolescent | Aged, 80 and over | Biomarkers, Tumor - metabolism | Epstein-Barr Virus Infections - genetics | Adult | Female | Aged | Epstein-Barr Virus Infections - metabolism | Lymphoma, Large B-Cell, Diffuse - genetics
Journal Article
Cancer Science, ISSN 1347-9032, 05/2017, Volume 108, Issue 5, pp. 1071 - 1079
Diffuse large B‐cell lymphoma (DLBCL) is the most common B‐cell lymphoma subtype, and the Epstein–Barr virus (EBV)‐positive subtype of DLBCL is known to show a...
NFκB | TAK1 | diffuse large B‐cell lymphoma | BACH2 | Epstein–Barr virus | diffuse large B-cell lymphoma | REPRESSOR BACH2 | ACTIVATION | NETWORK | CANCER | TRANSCRIPTION FACTOR BACH2 | CHROMOSOME 6Q15 | ONCOLOGY | SIGNALING PATHWAY | MEMBRANE-PROTEIN 1 | Epstein-Barr virus | GENE VARIABLE REGION | NF-KAPPA-B | NF kappa B | Basic-Leucine Zipper Transcription Factors - metabolism | Epstein-Barr Virus Infections - virology | Humans | Middle Aged | Child, Preschool | Male | NF-kappa B - metabolism | MAP Kinase Kinase Kinases - metabolism | Lymphoma, Large B-Cell, Diffuse - metabolism | Lymphoma, Large B-Cell, Diffuse - virology | Down-Regulation - physiology | Immunohistochemistry - methods | Young Adult | Transcription Factor RelA - metabolism | Adolescent | Aged, 80 and over | Adult | Female | Aged | Herpesvirus 4, Human - pathogenicity | Child | Epstein-Barr Virus Infections - metabolism | Immunohistochemistry | Bone morphogenetic proteins | Lymphomas | Analysis | Phosphorylation | Immunoglobulins | Aggressive behavior | TAK1 protein | Transforming growth factor | Homology | Infections | Hybridization | Kinases | Patients | Lymphoma | Hemopoiesis | Proteins | Clonal deletion | Lymphocytes B | Tumor suppressor genes | Localization | Growth factors | Original
NFκB | TAK1 | diffuse large B‐cell lymphoma | BACH2 | Epstein–Barr virus | diffuse large B-cell lymphoma | REPRESSOR BACH2 | ACTIVATION | NETWORK | CANCER | TRANSCRIPTION FACTOR BACH2 | CHROMOSOME 6Q15 | ONCOLOGY | SIGNALING PATHWAY | MEMBRANE-PROTEIN 1 | Epstein-Barr virus | GENE VARIABLE REGION | NF-KAPPA-B | NF kappa B | Basic-Leucine Zipper Transcription Factors - metabolism | Epstein-Barr Virus Infections - virology | Humans | Middle Aged | Child, Preschool | Male | NF-kappa B - metabolism | MAP Kinase Kinase Kinases - metabolism | Lymphoma, Large B-Cell, Diffuse - metabolism | Lymphoma, Large B-Cell, Diffuse - virology | Down-Regulation - physiology | Immunohistochemistry - methods | Young Adult | Transcription Factor RelA - metabolism | Adolescent | Aged, 80 and over | Adult | Female | Aged | Herpesvirus 4, Human - pathogenicity | Child | Epstein-Barr Virus Infections - metabolism | Immunohistochemistry | Bone morphogenetic proteins | Lymphomas | Analysis | Phosphorylation | Immunoglobulins | Aggressive behavior | TAK1 protein | Transforming growth factor | Homology | Infections | Hybridization | Kinases | Patients | Lymphoma | Hemopoiesis | Proteins | Clonal deletion | Lymphocytes B | Tumor suppressor genes | Localization | Growth factors | Original
Journal Article
Pathology - Research and Practice, ISSN 0344-0338, 12/2019, Volume 215, Issue 12, p. 152684
To investigate the relationship between immunoregulatory molecules B7-H4 and B7-H1 in Epstein-Barr positive diffuse large B-cell lymphoma (EBV DLBCL)....
Epstein-Barr positive diffuse large B-cell lymphoma | EBV | DLBCL | B7-H1 | B7-H4
Epstein-Barr positive diffuse large B-cell lymphoma | EBV | DLBCL | B7-H1 | B7-H4
Journal Article
Genes, Chromosomes and Cancer, ISSN 1045-2257, 06/2015, Volume 54, Issue 6, pp. 383 - 396
Viral oncogenes and host immunosenescence have been suggested as causes of Epstein‐Barr virus‐positive diffuse large B‐cell lymphoma (EBV + DLBCL) of the...
LIGAND-1 | PROGRAMMED CELL-DEATH-1 | ONCOLOGY | SUBTYPES | PATHWAY | GENETICS & HEREDITY | RIG-I | PREVALENCE | COMPARATIVE GENOMIC HYBRIDIZATION | LYMPHOPROLIFERATIVE DISORDERS | CLINICAL-SIGNIFICANCE | LYMPHOCYTES | Herpesvirus 4, Human - genetics | Humans | Middle Aged | Aged, 80 and over | Adult | Female | Male | Aged | Chromosomes, Human | Gene Expression Profiling | Lymphoma, B-Cell - genetics | DNA Copy Number Variations | Antiviral agents | Analysis | Genes | Genetic research | Lymphomas | Epstein-Barr virus | Gene expression
LIGAND-1 | PROGRAMMED CELL-DEATH-1 | ONCOLOGY | SUBTYPES | PATHWAY | GENETICS & HEREDITY | RIG-I | PREVALENCE | COMPARATIVE GENOMIC HYBRIDIZATION | LYMPHOPROLIFERATIVE DISORDERS | CLINICAL-SIGNIFICANCE | LYMPHOCYTES | Herpesvirus 4, Human - genetics | Humans | Middle Aged | Aged, 80 and over | Adult | Female | Male | Aged | Chromosomes, Human | Gene Expression Profiling | Lymphoma, B-Cell - genetics | DNA Copy Number Variations | Antiviral agents | Analysis | Genes | Genetic research | Lymphomas | Epstein-Barr virus | Gene expression
Journal Article
Modern Pathology, ISSN 0893-3952, 08/2011, Volume 24, Issue 8, pp. 1046 - 1054
Epstein-Barr virus (EBV)-positive diffuse large B-cell lymphoma of the elderly was included as a provisional entity in the 2008 WHO lymphoma classification....
EBV | Mexico | elderly | large cell lymphoma | EBV INFECTION | STRAIN TYPE | PROTEIN-1 ONCOGENE DELETIONS | PATHOLOGY | HODGKINS-DISEASE | GENE | LATENT MEMBRANE-PROTEIN | LYMPHOPROLIFERATIVE DISORDERS | ASSOCIATION | PLUS | Viral Matrix Proteins - biosynthesis | Herpesvirus 4, Human - genetics | Prevalence | Lymphoma, Large B-Cell, Diffuse - pathology | Mexico - epidemiology | Humans | Middle Aged | Male | Viral Matrix Proteins - analysis | Lymphoma, Large B-Cell, Diffuse - virology | Epstein-Barr Virus Infections - pathology | Germany - epidemiology | In Situ Hybridization | Epstein-Barr Virus Infections - etiology | Epstein-Barr Virus Nuclear Antigens - biosynthesis | Lymphoma, Large B-Cell, Diffuse - epidemiology | Age of Onset | Polymerase Chain Reaction | Female | Aged | Viral Proteins - biosynthesis | Epstein-Barr Virus Infections - epidemiology | Epstein-Barr Virus Nuclear Antigens - analysis | Viral Proteins - analysis
EBV | Mexico | elderly | large cell lymphoma | EBV INFECTION | STRAIN TYPE | PROTEIN-1 ONCOGENE DELETIONS | PATHOLOGY | HODGKINS-DISEASE | GENE | LATENT MEMBRANE-PROTEIN | LYMPHOPROLIFERATIVE DISORDERS | ASSOCIATION | PLUS | Viral Matrix Proteins - biosynthesis | Herpesvirus 4, Human - genetics | Prevalence | Lymphoma, Large B-Cell, Diffuse - pathology | Mexico - epidemiology | Humans | Middle Aged | Male | Viral Matrix Proteins - analysis | Lymphoma, Large B-Cell, Diffuse - virology | Epstein-Barr Virus Infections - pathology | Germany - epidemiology | In Situ Hybridization | Epstein-Barr Virus Infections - etiology | Epstein-Barr Virus Nuclear Antigens - biosynthesis | Lymphoma, Large B-Cell, Diffuse - epidemiology | Age of Onset | Polymerase Chain Reaction | Female | Aged | Viral Proteins - biosynthesis | Epstein-Barr Virus Infections - epidemiology | Epstein-Barr Virus Nuclear Antigens - analysis | Viral Proteins - analysis
Journal Article